PROCEPT BioRobotics Corp (PRCT)
Data as of , from SEC Form 4 filings.
Net insider buying (90d)Watch PRCT
See up to 3 months of PRCT. The 7-day demo opens the 1M and 3M ranges and puts PRCT on your watchlist.
Start 7-day demoLatest PRCT insider trades
- Alaleh Nouri - OfficerOpen-market sale$6K
Barry L. Templin
About PROCEPT BioRobotics Corp (PRCT)
PROCEPT BioRobotics Corp is an SEC registrant, filing under CIK 0001588978, classified as surgical and medical instruments and apparatus. It is grouped with Health Care companies on this site.
PRCT Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 1 | 23,900 | $498K |
| Open-market sale | 3 | 1,043 | $22K |
| Grant or award | 10 | 263,895 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
PRCT insider transactions (Form 4)
5644 Form 4 filings on record, the earliest from Oct 17, 2024, newest first. Filing history page 1 of 2.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Michael Mack - Director | Grant or award | Common Stock | 7,727 footnote F1 | $0.00 | - | |
| Michael Mack - Director | Grant or award | Stock Option (Right to Buy) | 12,191 | $0.00 | - | |
| ||||||
| Alaleh Nouri - Officer | Open-market sale | Common Stock | 297 | $20.95 | $6K | |
| Barry L. Templin - Officer | Open-market sale | Common Stock | 373 | $20.95 | $8K | |
| Kevin Waters - Officer | Open-market sale | Common Stock | 373 | $20.95 | $8K | |
| Alaleh Nouri - Officer | Grant or award | Common Stock | 22,965 footnote F1 | $0.00 | - | |
| Alaleh Nouri - Officer | Grant or award | Stock Option (Right to Buy) | 31,773 | $0.00 | - | |
| ||||||
| Barry L. Templin - Officer | Grant or award | Common Stock | 26,246 footnote F1 | $0.00 | - | |
| Barry L. Templin - Officer | Grant or award | Stock Option (Right to Buy) | 36,312 | $0.00 | - | |
| ||||||
| Kevin Waters - Officer | Grant or award | Common Stock | 29,527 footnote F1 | $0.00 | - | |
| Kevin Waters - Officer | Grant or award | Stock Option (Right to Buy) | 40,851 | $0.00 | - | |
| ||||||
| Pooja Sharma - Officer | Grant or award | Common Stock | 23,622 footnote F1 | $0.00 | - | |
| Pooja Sharma - Officer | Grant or award | Stock Option (Right to Buy) | 32,681 | $0.00 | - | |
| ||||||
| Larry L. Wood - Officer | Open-market purchase | Common Stock | 23,900 | $20.85 footnote F1 | $498K | |
| ||||||
| Antal Rohit Desai - Director | Grant or award | Common Stock | 3,315 | $0.00 | - | |
| Antal Rohit Desai - Director | Grant or award | Stock Option (Right to Buy) | 5,853 | $0.00 | - | |
| Amy M. Dodrill - Director | Grant or award | Common Stock | 3,315 | $0.00 | - | |
| Amy M. Dodrill - Director | Grant or award | Stock Option (Right to Buy) | 5,853 | $0.00 | - | |
 Mary Garrett - Director | Grant or award | Common Stock | 3,315 | $0.00 | - | |
| Mary Garrett - Director | Grant or award | Stock Option (Right to Buy) | 5,853 | $0.00 | - | |
| Taylor C. Harris - Director | Grant or award | Common Stock | 3,315 | $0.00 | - | |
| Taylor C. Harris - Director | Grant or award | Stock Option (Right to Buy) | 5,853 | $0.00 | - | |
| Elisabeth Sandoval - Director | Grant or award | Common Stock | 3,315 | $0.00 | - | |
| Elisabeth Sandoval - Director | Grant or award | Stock Option (Right to Buy) | 5,853 | $0.00 | - | |
| Frederic H. Moll - Director | Grant or award | Common Stock | 3,315 | $0.00 | - | |
| Frederic H. Moll - Director | Grant or award | Stock Option (Right to Buy) | 5,853 | $0.00 | - | |
| Thomas M. Prescott - Director | Grant or award | Stock Option (Right to Buy) | 5,853 | $0.00 | - | |
| Thomas M. Prescott - Director | Grant or award | Common Stock | 3,315 | $0.00 | - | |
| Dan Puckett - Director | Grant or award | Common Stock | 3,315 | $0.00 | - | |
| Dan Puckett - Director | Grant or award | Stock Option (Right to Buy) | 5,853 | $0.00 | - | |
| Alaleh Nouri - Officer | Open-market sale | Common Stock | 285 footnote F1 | $28.48 | $8K | |
| ||||||
| Kevin Waters - Officer | Open-market sale | Common Stock | 357 footnote F1 | $28.48 | $10K | |
| ||||||
| Barry L. Templin - Officer | Open-market sale | Common Stock | 358 footnote F1 | $28.48 | $10K | |
| ||||||
| Alaleh Nouri - Officer | Open-market sale | Common Stock | 304 footnote F1 | $28.15 | $9K | |
| ||||||
| Kevin Waters - Officer | Open-market sale | Common Stock | 706 footnote F1 | $28.15 | $20K | |
| ||||||
| Alaleh Nouri - Officer | Open-market sale | Common Stock | 3,098 | $25.60 footnote F2 | $79K | |
| Alaleh Nouri - Officer | Open-market sale | Common Stock | 145 | $26.74 footnote F3 | $4K | |
| ||||||
| Antal Rohit Desai | Open-market purchase | Common Stock | 53,818 | $24.91 footnote F7 | $1.34M | |
| Antal Rohit Desai | Open-market purchase | Common Stock | 1,300 | $25.42 footnote F8 | $33K | |
| Antal Rohit Desai | Open-market purchase | Common Stock | 142,498 | $25.44 footnote F1 | $3.63M | |
| Antal Rohit Desai | Open-market purchase | Common Stock | 24,748 | $26.41 footnote F3 | $654K | |
| Antal Rohit Desai | Open-market purchase | Common Stock | 106,554 | $23.33 footnote F4 | $2.49M | |
| Antal Rohit Desai | Open-market purchase | Common Stock | 53,763 | $24.10 footnote F5 | $1.30M | |
| Antal Rohit Desai | Open-market purchase | Common Stock | 43,581 | $24.08 footnote F6 | $1.05M | |
| ||||||
| Larry L. Wood - Officer | Grant or award | Common Stock | 127,783 footnote F1 | $0.00 | - | |
| Larry L. Wood - Officer | Grant or award | Stock Option (Right to Buy) | 103,653 | $0.00 | - | |
| ||||||
| Alaleh Nouri - Officer | Open-market sale | Common Stock | 6,892 footnote F2 | $23.70 | $163K | |
| Alaleh Nouri - Officer | Grant or award | Stock Option (Right to Buy) | 29,615 | $0.00 | - | |
| Alaleh Nouri - Officer | Grant or award | Common Stock | 43,811 footnote F1 | $0.00 | - | |
| ||||||
| Kevin Waters - Officer | Open-market sale | Common Stock | 6,721 footnote F2 | $23.70 | $159K | |
| Kevin Waters - Officer | Grant or award | Stock Option (Right to Buy) | 32,576 | $0.00 | - | |
| Kevin Waters - Officer | Grant or award | Common Stock | 47,462 footnote F1 | $0.00 | - | |
| ||||||
| Dan Puckett - Director | Grant or award | Stock Option (Right to Buy) | 8,897 | $0.00 | - | |
| Dan Puckett - Director | Grant or award | Common Stock | 5,476 footnote F1 | $0.00 | - | |
| ||||||
| Alaleh Nouri - Officer | Grant or award | Common Stock | 4,872 footnote F1 | $0.00 | - | |
| ||||||
| Kevin Waters - Officer | Grant or award | Common Stock | 3,532 | $0.00 | - | |
Item 5.02, 9.01
Item 1.01, 9.01
Item 2.02, 9.01
Item 5.07
Recent PRCT Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Kevin Waters | Officer | 373 | $8K | View on EDGAR | |
| Barry L. Templin | Officer | 373 | $8K |
PRCT insider trading FAQ
What is the latest insider trade for PRCT?
PROCEPT BioRobotics Corp (PRCT) had 9 insider filings in the last 90 days, with the most recent on 5 October 2026. The full record for PRCT runs to 44 Form 4 filings, the earliest from 17 October 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying PRCT stock?
1 insider purchase of PRCT was filed in the last 90 days, totaling $498K.
How many insiders are selling PRCT stock?
3 insider sales of PRCT were filed in the last 90 days, totaling $22K.
Where can I see PRCT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects PRCT Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Michael Mack view on EDGAR
- - Alaleh Nouri view on EDGAR
- - Barry L. Templin view on EDGAR
- - Kevin Waters view on EDGAR
- - Alaleh Nouri view on EDGAR
- - Barry L. Templin view on EDGAR
- - Kevin Waters view on EDGAR
- - Pooja Sharma view on EDGAR
- - Larry L. Wood view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where PRCT's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow PRCT with a 7-day demo
- PRCT on your watchlist
- Every PRCT Form 4 filing on record
- Up to 3 months of PRCT price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
